Abstract

Purpose: We aimed to identify potential risk factors predictive of metastasis at initial diagnosis in Ewing sarcoma patients.Patients and methods: We enrolled selected patients diagnosed with Ewing sarcoma between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) Program database. Demographic and clinical features of patients were analyzed to demonstrate the potential risk factors of distant metastasis at presentation. We utilized descriptive statistics, univariate methods, and a series of regression models to analyze the significance of risk factors. Moreover, we conducted survival analysis in patients with different metastatic sites through Kaplan–Meier analysis.Results: We identified 1,066 cases of Ewing sarcoma and 332 (31.1%) of the patients had metastasis at initial diagnosis. In the univariate logistic regression analysis, patients had higher probability of metastasis at initial diagnosis if they aged between 18 and 59 years old (OR = 1.43; 95% CI, 1.09 to 1.86), had a tumor located in the axial or cranial bones (OR = 1.38; 95% CI, 1.05 to 1.81), or had a tumor over 8 cm (OR = 2.55; 95% CI, 1.66 to 3.89). These three factors were still significant when analyzed in a multivariate logistic regression model or another multivariate logistic regression model controlling for age, location, and tumor size, which had univariate p < 0.1. Besides, we found that patients with lung metastasis alone had a better prognosis than patients with bone metastasis alone or with two or more metastatic sites (p < 0.01).Conclusion: Ewing sarcoma patients with an age between 18 and 59 years old, a tumor in the axial or cranial bones, and a tumor size over 8 cm had an increased likelihood to have metastatic diseases at initial diagnosis.

Highlights

  • Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children and young people, following osteosarcoma [1]

  • Most of the 1,066 cases occurred in children, adolescents, and young people, which consists with previous research (Figure 2) [7]

  • We found that 31.1% of ES patients had distant metastasis at initial diagnosis

Read more

Summary

Introduction

Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children and young people, following osteosarcoma [1]. Owing to the advance in surgery, radiation, and multidrug chemotherapy in the last few decades, the 5 year overall survival rate of the patients with localized ES has been improved to nearly 75% [2]. The 5 year survival rate of patients with metastasis is only 20–45%, depending on the metastatic sites [3]. It is reported that approximately 25% of ES patients have metastatic diseases at initial diagnosis [4]. Little is known about risk factors related to higher odds of metastasis at initial diagnosis in ES patients.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call